Oncologist

Medical Director for Oncology Developmental Therapeutics

The successful candidate will be an integral part of the cancer institute’s growth and will report to the local Oncology market leader. Duties will be split approximately 50% clinical and 50% administrative effort in support of the system-wide growth of the Developmental therapeutics Program of the Cancer Institute. The successful candidate should have early phase developmental therapeutics training and focus, record of regulatory authority interactions, organization of translational research studies, and/or organization of investigator‑initiated studies, and experience in the pharmaceutical industry being desirable.

Responsibilities

• Provides medical direction and oversight of early phase clinical trials – either directly as PI or support of colleagues who may be the PI in early phase studies but collaborate with the Developmental Therapeutics program for the safe conduct.
• Identifies growth opportunities and leads the development of the strategies for early phase clinical trials across all solid tumor populations and close interaction with her/his hematology colleagues.
• Initiates and serves as the physician lead for the Developmental Therapeutics working group and supports other PIs in the development and prioritization of trials that best fit the needs of our patients.
• Responsible for assisting in recruitment, hiring and mentorship of developmental therapeutics faculty as the program matures.
• Acts as liaison for translational collaborations with pre‑clinical colleagues, helping identify pre‑clinical assets and leading first‑in‑human studies to support development of assets generated inside labs, as well as outside.
• Serves as PI and authors early phase clinical trials across all solid tumors and provides mentorship to colleagues in the field of oncology developmental therapeutics.
• Works to optimize the opening, accrual and management of a balanced portfolio of cutting‑edge first‑in‑human trials with the goal of establishing Novant Health as an early phase trial destination for patients, research organizations, and pharmaceutical companies.
• Develops and maintains a national reputation for the conduct of early phase clinical trials.
• Develops priorities in collaboration with leadership that support the needs of the catchment area in providing cancer patients with access to trials.
• Demonstrates a collegial, collaborative interpersonal style and the ability to implement inclusive approaches for early phase clinical research across the portfolio.
• Maintains strong relationships with key stakeholders and partners in external collaborative efforts (universities, government agencies, not‑for‑profit organizations, pharma/biotech companies).
• Acts as the primary liaison between faculty, clinical management (infusion, pharmacy, laboratory), the clinical trials office staff and leadership when resolving conflicts and/or identifying areas in need of improvement important for the conduct of early phase clinical trials.
• Assists in CTO staff caseloads and helps determine when and how reallocations should be made and communicates these plans as necessary.
• Participates in audit debriefings, reviews all audit/monitoring visit reports (internal and external), and works with the CTO staff to develop, implement, and monitor corrective action plans; communicates these plans with leadership to determine best methods for disseminating communications regarding these corrective action plans with faculty and clinical staff.
• Monitors time to activation metrics for Phase I studies and works with clinical trials management to impact improvements.
• Works with the regulatory team to develop and monitor per study and annual Developmental Therapeutics specific budgets and advocates to leadership when additional resources are needed.
• Meets with Cancer Institute leadership as required to review issues, accomplishments, and plans for growth.
• Regularly attends and actively participates in clinical trial management team meetings and institute committees designed to demonstrate oversight and ensure the safe conduct of human research.
• Participates institutional review boards and liaison with university partners for such clinical research oversight requirements as appointed by cancer institute leadership.
• Integrates and supports the growth of the Developmental Therapeutics program system wide.

Candidate Qualifications

• Board‑certified or board‑eligible in Medical Oncology and Hematology

Benefits & Perks

• Comprehensive medical and retirement benefits
• Paid leave benefits
• Malpractice coverage
• Emphasis on work‑life balance
• Employment with NH Medical Group
• Eligible for Public Service Loan Forgiveness

Additional Compensation Details

• Two‑year salary guarantee
• Relocation allowance
• Continuing Medical Education (CME) allowance

Job Opening ID: 75977